Talk:Contract research organization

Pharmacology Start‑class Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Start	This article has been rated as Start-class on Wikipedia's content assessment scale.
Mid	This article has been rated as Mid-importance on the project's importance scale.

Wikify

A version of this article was wikified by Nolelover, a member of WikiProject Wikify, on October 8, 2010. The project welcomes all editors with a good grasp of wiki markup to help improve articles. Visit our project page if you're interested in joining! If you have questions, please ask at our talk page.WikifyWikipedia:WIKITemplate:WikiProject WikifyWikify articles

There are non-medical CROs, too; they just aren't as common. I don't know enough about the market to add this formally to the article.

Clinical Research Organization or Contract Research Organization

Is there a difference between these two definitions of CRO?

Merger from Contract Research Organization

This is the text from Contract Research Organization, which can be merged with this article.Marasmusine 11:31, 29 August 2006 (UTC)[reply]

A Contract Research Organization (CRO) is an organization that offers clients a wide range of pharmaceutical research services. In the Code of Federal Regulations (CFR), the U.S. Food and Drug Administration regulations state that a CRO is "a person [i.e., a legal person, which may be a corporation] that assumes, as an independent contractor with the sponsor, one or more of the obligations of a sponsor, e.g., design of a protocol, selection or monitoring of investigations, evaluation of reports, and preparation of materials to be submitted to the Food and Drug Administration." [21 CFR 312.3(b)]

Services offered by CROs include: product development and formulation, clinical trial management (preclinical through phase IV), central laboratory services for processing trial samples, data management services for preparation of an FDA New Drug Application (NDA) or an Abbreviated New Drug Application (ANDA), and many other complementary services. CROs can offer their clients the experience of moving a new drug from its conception to FDA marketing approval without the drug sponsor having to maintain a staff for these services, which often have limited duration. [1]

I went ahead and put this text in to replace the old introduction paragraph anyway. Marasmusine 11:53, 29 August 2006 (UTC)[reply]

eCRO vs. CRO

It seems to me absurd to distinguish between these as I believe most CROs now utilized much digital infrastructure in their operations. Is there any evidence that this is anything more than marketing? --Xris0 04:37, 6 September 2007 (UTC)[reply]

If there aren't any good sources added to defend this distinction I'm going to delete this section because it doesn't make sense to me. --Xris0 (talk) 07:03, 7 January 2008 (UTC)[reply]

CRO list

The CROlike it is being modified by CROs to jockey their positions/appearance... probably should be watched to make sure it reflects an unbiased presentation. I removed eCRO tags per the above section. I combined a separate "Global CRO" list because I noticed that some of the CROs in the other sections were global and this distinction should probably only be made if all the organizations are put in the proper place, rather than one company putting itself in the separate section and leaving the others out (ie. what someone appeared to have done, ahem). I also changed link titles that were all caps and removed extraneous information (ie. stock ticker information). Trying to keep everything neutral...--Xris0 18:18, 16 October 2007 (UTC)--Xris0 18:18, 16 October 2007 (UTC)[reply]

Some CROs are listing their locations... might want to either not list locations or try to list for all to be balanced. On one hand might be useful to break down in countries, but that might be complicated due to, for example, USA-based CROs having operations in other countries.--Xris0 (talk) 03:36, 29 November 2007 (UTC)[reply]

I had added a CRO link on wikipedia as i could see other links on this artile but that link was removed. i represent a cro in india and want to know that why it was deleted. The cro is Fermish Clinical Technologies Pvt Ltd —Preceding unsigned comment added by 122.162.157.143 (talk) 03:25, 10 December 2007 (UTC)[reply]

You are not following NPOV edit guidelines. You are adding 3 links for yourself on the top, and putting in distinguishing descriptive text. This isn't rocket science; just add a single simple link like all the others or stop wasting editors' time by editing this page. --Xris0 (talk) 07:00, 7 January 2008 (UTC)[reply]

I am not the person above, but I didn't think I was wasting editors time when I added a link to Siro Clinpharm which is the largest CRO in India, under Contract Research Organizations a week or so back. I didn't think you'll should have deleted just because it does not have its own Wiki page and the link was to the Siro Clinpharm Website. --123.236.29.73 (talk) 16:06, 4 August 2008 (UTC)[reply]

How about changing it from "Notable CROs" to "Top CROs by Revenue" or provide some other clear criteria for inclusion? Otherwise we're going to end up with a massive list of CROs who are the largest in their own country but otherwise not particularly notable. TomorrowsDream (talk) 11:55, 28 April 2009 (UTC)[reply]

Clean-up of lists

Well Wikipedia is not supposed to be a list of links for one and secondly that list is far from comprehensive. There are several, including the one that I work for, that are larger, have more international coverage in the media and are more notable than several in that list. If the CRO is important it should have its own article.Peter Rehse (talk) 13:31, 2 May 2008 (UTC)[reply]

I notice the one I work for is in the list but still the point still stands as marked by the clean-up tag. If the company is important it should have its own article.Peter Rehse (talk) 13:35, 2 May 2008 (UTC)[reply]

Article Update and Addition of References

Made a proposed significant update to the article, as citations and references were completely absent, and the introductory section was relatively incorrect. Edits are encouraged, references to publicly-available external articles should be accurate. Azupnick (talk) 21:36, 7 January 2009 (UTC)[reply]

It's not proposed if you made the edits in the mainspace. :) You might want to look at WP:MOS to see Wikipedia's writing style and WP:RS for sourcing info. There are editors who can help with technical and trade sourcing as well. Flowanda | Talk 23:00, 7 January 2009 (UTC)[reply]

Speedy Deletion

This is a valid encyclopedic article within the Pharmaceutical industry category unless the information is covered in a more appropriate article (and if so, where?). It is by no means spam. Company-specific information that constituted advertising has already been removed. The article needs improved structure to bring it up to encyclopedia standards. The article should be expanded to address: (a) the criticality to pharmaceutical development as pharma companies can no longer afford to maintain their own large organisations, (2) the different types of CROs (clinical, central labs etc), (3) the different models of CRO outsourcing (full service vs functional). TomorrowsDream (talk) 08:24, 27 July 2009 (UTC)[reply]

Big press release?

Damien, do you know what you are talking about? I don't see how a report from IMS Health about the future growth of the CRO market constitutes a "big press release" or advertising. Instead of just deleting half the article, perhaps you could spend some time improving it or even providing some justification for excessive editing? TomorrowsDream (talk) 14:33, 22 July 2011 (UTC)[reply]